What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
His primary areas of study are Surgery, Radiation therapy, Internal medicine, Oncology and Radiosurgery.
The concepts of his Surgery study are interwoven with issues in Glioma and Hazard ratio.
His biological study spans a wide range of topics, including Cancer, Progression-free survival, Prospective cohort study, Pathology and Oligodendroglioma.
Internal medicine connects with themes related to Gastroenterology in his study.
As part of the same scientific family, Paul D. Brown usually focuses on Oncology, concentrating on Carcinoma and intersecting with Retrospective cohort study.
Paul D. Brown interconnects Brain metastasis, Nuclear medicine, Magnetic resonance imaging, Sarcoma and Cognitive decline in the investigation of issues within Radiosurgery.
His most cited work include:
- A Randomized Trial of Bevacizumab for Newly Diagnosed Glioblastoma (1528 citations)
- Summary Report on the Graded Prognostic Assessment: An Accurate and Facile Diagnosis-Specific Tool to Estimate Survival for Patients With Brain Metastases (830 citations)
- Diagnosis-Specific Prognostic Factors, Indexes, and Treatment Outcomes for Patients With Newly Diagnosed Brain Metastases: A Multi-Institutional Analysis of 4,259 Patients (668 citations)
What are the main themes of his work throughout his whole career to date?
Paul D. Brown mainly investigates Internal medicine, Radiation therapy, Oncology, Radiosurgery and Surgery.
His work in the fields of Internal medicine, such as Temozolomide, Clinical trial, Proportional hazards model and Randomized controlled trial, overlaps with other areas such as In patient.
Paul D. Brown combines subjects such as Cancer, Chemotherapy, Retrospective cohort study, Glioma and Prospective cohort study with his study of Radiation therapy.
His research in Oncology intersects with topics in Neurocognitive, Newly diagnosed, Glioblastoma and Hazard ratio.
His Radiosurgery research is multidisciplinary, incorporating perspectives in Metis, Brain metastasis and Nuclear medicine.
The various areas that he examines in his Surgery study include Multivariate analysis and Cohort.
He most often published in these fields:
- Internal medicine (29.66%)
- Radiation therapy (23.33%)
- Oncology (23.79%)
What were the highlights of his more recent work (between 2018-2021)?
- Radiosurgery (21.26%)
- Internal medicine (29.66%)
- Oncology (23.79%)
In recent papers he was focusing on the following fields of study:
Paul D. Brown mainly focuses on Radiosurgery, Internal medicine, Oncology, Radiology and Radiation therapy.
The Radiosurgery study combines topics in areas such as Brain metastasis, Radiography, Nuclear medicine, Hazard ratio and Cohort.
His study in the fields of Clinical trial, Memantine and Quality of life under the domain of Internal medicine overlaps with other disciplines such as In patient.
His Oncology research focuses on subjects like Randomized controlled trial, which are linked to Proton therapy and Progression-free survival.
He works mostly in the field of Radiology, limiting it down to topics relating to Metis and, in certain cases, INFRATENTORIAL BRAIN.
He mostly deals with Temozolomide in his studies of Radiation therapy.
Between 2018 and 2021, his most popular works were:
- Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001. (107 citations)
- Treatment of Brain Metastases With Stereotactic Radiosurgery and Immune Checkpoint Inhibitors: An International Meta-Analysis of Individual Patient Data (71 citations)
- Single versus Multifraction Stereotactic Radiosurgery for Large Brain Metastases: An International Meta-analysis of 24 Trials. (50 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
His main research concerns Internal medicine, Oncology, Radiosurgery, Radiation therapy and Radiology.
In general Internal medicine study, his work on Clinical trial, Hazard ratio, Proportional hazards model and Cancer often relates to the realm of In patient, thereby connecting several areas of interest.
His Oncology study integrates concerns from other disciplines, such as Retrospective cohort study, Breast cancer, Cohort and Glioma.
His Radiosurgery research includes elements of Incidence, Brain metastasis, Regimen, Meta-analysis and Prospective cohort study.
His primary area of study in Radiation therapy is in the field of Temozolomide.
His Radiology research incorporates themes from Skull, Logistic regression, Neuropathic pain, Analgesic and Cell brain.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
